TICKERNERD
Menu
ALGNALGNHealthcare · Medical Instruments & Supplies

ALGN Stock Forecast: Align Technology, Inc. Price Predictions for 2026-2027

Last close, 18 Aug 2026
$168
−1.90% on the day

The 17 Wall Street analysts covering Align Technology, Inc. hold a median 12-month price target of $209 — +24.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 82 of 100 as at 17 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$12.2B
Ticker Nerd rank
82 / 100
Median analyst target
$209
Analysts covering
17
Total return, dividends reinvested
1W
−2.9%
1M
−5.0%
YTD
+7.5%
1Y
+15.8%
From 52W high
−15.0%
From 52W low
+34.5%
$125
$198
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ALGN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Align Technology, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 17 Aug 2026
82 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
95
Issuance
83
Quality
82
Accruals
73
Volatility
68
Growth
65
Revisions
55
Momentum
46
Size
14

Value (95): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (46): The shares have been drifting down relative to others.

Size (14): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ALGN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ALGN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$120$140$160$180$200$220$240Oct 25Jan 26Apr 26Jul 26ALGNHigh $240Median $209Low $170

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says17 analysts
10 Buy6 Hold1 Sell
Low $170Median $209High $240

The green dot is the last close — the median target sits +24.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
9 July 2026BMO CapitalInitiatesOutperform$209
30 Apr 2026Evercore ISI GroupMaintainsOutperform—
24 Apr 2026Morgan StanleyMaintainsEqual-Weight—
21 Apr 2026Piper SandlerMaintainsOverweight—
15 Apr 2026CitigroupInitiatesBuy—
17 Mar 2026BarclaysUpgradeOverweight—
26 Feb 2026BarclaysMaintainsEqual-Weight—
9 Feb 2026HSBCUpgradeBuy—
5 Feb 2026Evercore ISI GroupMaintainsOutperform—
5 Feb 2026Morgan StanleyMaintainsEqual-Weight—
5 Feb 2026Piper SandlerMaintainsOverweight—
5 Feb 2026StifelMaintainsBuy—
5 Feb 2026UBSMaintainsNeutral—
5 Feb 2026Wells FargoMaintainsOverweight—
20 Jan 2026MizuhoMaintainsOutperform—
9 Dec 2025BarclaysInitiatesEqual-Weight—
30 Oct 2025Evercore ISI GroupMaintainsOutperform—
30 Oct 2025Morgan StanleyMaintainsEqual-Weight—
30 Oct 2025Piper SandlerReiteratesOverweight—
30 Oct 2025Wells FargoMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALGN appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

ALGN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−0.6%
Analysts raising
1
Analysts cutting
2
Fundamentals

Align Technology, Inc. (ALGN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
29.7×

Cheaper than 27% of US stocks

Price / sales
2.9×

Cheaper than 43% of US stocks

Price / book
2.9×

Cheaper than 36% of US stocks

EV / EBITDA
12.3×

Cheaper than 31% of US stocks

Growth & margins
Revenue growth (YoY)
4.3%

Higher than 37% of US stocks

Earnings growth (YoY)
−13.1%

Higher than 24% of US stocks

Gross margin
71.7%

Higher than 84% of US stocks

Operating margin
18.2%

Higher than 77% of US stocks

Net margin
10.0%

Higher than 70% of US stocks

Returns & dividend
Return on equity
10.2%

Higher than 64% of US stocks

Return on assets
7.4%

Higher than 86% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ALGN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Instruments & Supplies
CompanyMarket capTKN rank
ALGNAlign Technology, Inc.$12.2B
82
BAXBaxter International, Inc.$13.3B
89
COOThe Cooper Cos., Inc.$14.7B
77
SOLVSolventum Corp.$15.1B
89
RGENRepligen Corp.$9.5B
90
AVTRAvantor, Inc.$9.2B
79
ATRAptarGroup, Inc.$8.6B
47

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Align Technology, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ALGN news & analysis

How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook

Zacks Investment Research · 17 Aug 2026negative

Align Technology faces a $37.5 million U.K. VAT liability, new 20% VAT charges, and a pending appeal, adding fresh earnings uncertainty amid currency and product-mix pressures, according to Zacks Investment Research.

Why it matters — A ALGN watcher would care because the U.K. VAT ruling introduces new financial obligations and appeal-related uncertainty that could weigh on the company's 2026 earnings outlook.

Should Investors Buy Align as Growth Meets Valuation and Demand Risks?

Zacks Investment Research · 14 Aug 2026neutral

Zacks Investment Research examines Align Technology's investment case, noting record Clear Aligner growth and global adoption as supporting the bull case, while flagging demand softness and scanner pricing pressure as cautionary factors for investors.

Why it matters — ALGN watchers would care because this analysis weighs the company's strong Clear Aligner momentum against ongoing demand and pricing headwinds that could influence its near-term outlook.

Align Technology Prevails in China Patent Infringement Action Against Angelalign

Business Wire · 12 Aug 2026positive

Align Technology announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China. Align filed the action in September 2025.

Why it matters — A legal win in a Chinese patent infringement case against a competitor could strengthen Align's intellectual property position in a key market.

Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple

Seeking Alpha · 7 Aug 2026positive

Align Technology reported record revenue, volume, and operating margins, trading near five-year valuation lows despite structural business improvements. Competitive pressures eased after SmileDirectClub's exit, with shifting growth toward international and DSO channels, expanding margins, raised guidance, and an active buyback program supported by strong free cash flow.

Why it matters — The piece highlights that Align Technology is delivering record financial results and structural improvements while trading at historically low valuations, which is notable for ALGN watchers assessing the company's earnings momentum and competitive position.

Align Technology: Attractively Valued But Growth Still Needs To Pick Up

Seeking Alpha · 31 July 2026neutral

Align Technology reported record Q2 revenue and clear aligner volumes, with strong international growth offsetting stagnation in North America. The company continues its strategy of expanding its digital dentistry platform to drive recurring revenue.

Why it matters — ALGN watchers would care because despite a record quarter in revenue and volumes, the company's North American growth remains flat and overall growth velocity is still a concern for investors evaluating its valuation.

FAQ

Frequently asked questions about ALGN stock

What is the ALGN stock price forecast for 2026-2027?

The 17 Wall Street analysts covering Align Technology, Inc. have a median 12-month price target of $209, with estimates ranging from $170 to $240. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ALGN stock a buy right now?

Of the 17 analysts covering Align Technology, Inc., 10 rate it a Buy, 6 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Align Technology, Inc. 82 out of 100 across roughly 4,600 US stocks as at 17 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ALGN?

As at 17 Aug 2026, Align Technology, Inc. ranks 82 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (95 of 100).

Will ALGN stock go up?

No one can know that. What the data says: the median 12-month target from 17 analysts implies +24.5% from the last close, and Ticker Nerd's factor model ranks Align Technology, Inc. 82 out of 100 as at 17 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ALGN stock forecast for 2030?

No analyst covering Align Technology, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALGN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $170 to $240 over the next 12 months.

How has ALGN stock performed over the past year?

Align Technology, Inc. returned +15.8% over the 12 months to 18 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Align Technology, Inc. do?

Align Technology, Inc. is a medical device company specializing in digital orthodontics and restorative dentistry solutions.

What is the latest news on ALGN?

The most recent item we track (Zacks Investment Research, 17 Aug 2026): "How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook". Align Technology faces a $37.5 million U.K. VAT liability, new 20% VAT charges, and a pending appeal, adding fresh earnings uncertainty amid currency and product-mix pressures, according to Zacks Investment Research.

Company

About Align Technology, Inc.

Align Technology, Inc. is a medical device company specializing in digital orthodontics and restorative dentistry solutions. Its primary business centers on clear aligner therapy through the Invisalign product family, which is used to treat a wide range of malocclusion cases in collaboration with trained dentists and orthodontists worldwide. The company also operates a Systems and Services segment built around its iTero intraoral scanners and related software, providing digital scanning, treatment visualization, and integrated workflows for dental practices and laboratories. This includes hardware platforms, orthodontic and restorative software options, subscription services, upgrades, disposables, and CAD/CAM software from exocad that links practices to dental labs. Together, these products position Align Technology as a key player in the shift toward digital, chairside, and impressionless dentistry. Founded in 1997 and headquartered in Tempe, Arizona, Align Technology serves dental professionals globally across the healthcare and medical instruments and supplies sector.

CEO Mr. Joseph M. Hogan · 20,435 employees · United States · https://www.aligntech.com